Retina/Vitreous News

Vitreous floaters are a common ocular condition, affecting up to 76% of the population, according to Webb and colleagues.

A 23-year-old man was referred by an outside optometrist to the retina service at Ophthalmic Consultants of Boston for evaluation of 2 weeks of bilateral “flashes and zigzags.”

Vitreous opacities have many names including vitreous floaters and mouches volantes.

ATHENS, Greece — Retinal re-detachment following cataract extraction remains significant in patients who have previously undergone pars plana vitrectomy for retinal detachment, according to a study.

  The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, according to a press release from ANI Pharmaceuticals.

Altris AI, which offers OCT analysis for retinal diseases, is now expanding to glaucoma detection.

  The FDA approved Encelto, an encapsulated cell therapy, for the treatment of macular telangiectasia type 2, according to a press release from Neurotech Pharmaceuticals.

Older patients with diabetic macular edema have a weaker response to anti-VEGF treatment, according to a presentation at Angiogenesis, Exudation, and Degeneration 2025.

Geographic atrophy lesion location may be a critical factor in vision-related quality of life, according to a presentation at Angiogenesis, Exudation, and Degeneration 2025.